TrialThe Lancet. Microbe2025

Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study.

Taryn A Eubank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.